Clinical

Dataset Information

Safety comformation study of R435 (Bevacizumab) in patients with metastatic colorectal cancer


ABSTRACT: Interventions: investigational material(s) Generic name etc : Bevacizumab INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Injection Primary outcome(s): Safety Study Design: Open, Single Arm study

DISEASE(S): Metastatic Colorectal Cancer

PROVIDER: 99347 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR